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http://dx.doi.org/10.1016/j.stemcr.2017.05.012SUMMARYBoth the promises and pitfalls of the cell reprogramming research platform rest on human genetic variation,making themeasurement of
its impact one of themost urgent issues in the field. Harnessing large transcriptomics datasets of induced pluripotent stem cells (iPSC), we
investigate the implications of this variability for iPSC-based disease modeling. In particular, we show that the widespread use of more
than one clone per individual in combination with current analytical practices is detrimental to the robustness of the findings. We then
proceed to identifymethods to address this challenge and leveragemultiple clones per individual. Finally, we evaluate the specificity and
sensitivity of different sample sizes and experimental designs, presenting computational tools for power analysis. These findings and
tools reframe the nature of replicates used in disease modeling and provide important resources for the design, analysis, and interpreta-
tion of iPSC-based studies.INTRODUCTION
Induced pluripotent stem cells (iPSCs), and more broadly
the technologies emerging around cell reprogramming,
have developed rapidly and are already transforming
biomedical research. The defining, paradigm-shifting
innovation of the iPSC-based research platform is the
possibility of repeating development, which should be
understood not merely as the in vitro reproduction of
developmental processes, but as the feat of making it
repeatable, i.e., transforming hitherto unique organismal
processes—the development of a given individual—into
something experimentally and statistically tractable.
As such, cell reprogramming has made human genetic
variability amenable to experimentation. Indeed, as was
emphasized early on (Colman, 2008), a key asset of iPSCs
is that, contrary to embryonic stem cells (ESCs), they
are associated with medical histories and thus pave the
way to what we previously described as the functional
annotation of human genomes (Adamo et al., 2015), in
terms of genotype-phenotype correlation and disease
impact.
Yet at the same time the extent of human variability, of
whichwe are only beginning to take the fullmeasure, poses
an important practical problem for the field of iPSC-based
modeling. Given background genetic differences between
individuals, the key question is which experimental de-
signs and degrees of replication are necessary for robust
and sensitive results, and what are the best measures
to guide their selection. Here, we address such questions
by harnessing the large datasets recently made available
by the Human Induced Pluripotent Stem Cell Initia-
tive (HipSci; Streeter et al., 2016; Kilpinen et al., 2016)1784 Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017 j ª 2017 The Au
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NextGen consortium (Carcamo-Orive et al., 2016). We
derive empirically groundedmethodological recommenda-
tions for the design and analysis of iPSC-based studies.
Given the accessibility of expression profiling and the
critical importance of gene expression for the regulation
of cellular identity and function, transcriptomic dysregula-
tions have emerged for their rapid and informative insight
into the molecular underpinning of diseases, representing
for many a first high-content in vitro phenotype. This is
especially true for many diseases such as neurodevelop-
mental disorders, for which the iPSC technology is of prime
relevance due to the inaccessibility of the relevant tissues,
and whose main disease-associated genes are strongly en-
riched for transcription factors and chromatin regulators
(De Rubeis et al., 2014). Transcription is therefore of key
importance in itself, as well as representing a powerful
stand-in for other, more directly functional assays.RESULTS
Differences between Individuals Dominate the iPSC
Transcriptional Variance
In addition to the condition under study, transcriptomes
from iPSC lines can vary because of several factors that
can coarsely be boxed into genetic, epigenetic, and tech-
nical. Although skin biopsies harbor somatic mutations
(Young et al., 2012) and a minority of epigenetic marks
can be retained upon reprogramming (Kim et al., 2010),
the majority of differences between individuals are most
likely due to genetic variation. Conversely, while different
iPSC clones from the same individual tend to have minorthor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Spurious Differential Expres-
sion between Groups of Random
Individuals
Scheme of the types of permutations (A),
below which are shown the corresponding
distributions of the number of spurious
DEGs in the HipSci (B and C; 500 permuta-
tions each) and NHLBI/GSE79636 (D and E;
50 permutations each) datasets. For reasons
of visibility, the y axis of (D) is on a log
scale. Red bars indicate the mean of each
distribution. See also Figures S1–S4.genetic differences chiefly due to mosaicism in the initial
sample (Young et al., 2012; Ji et al., 2012) and ensuing se-
lection (Kilpinen et al., 2016), most of the variability is
likely related to differences in the epigenetic state of the
cells (Salomonis et al., 2016). Finally, differences between
RNA-sequencing (RNA-seq) libraries of the same clone are
most likely to capture essentially technical sources of
variation. As previously reported (Kilpinen et al., 2016; Car-
camo-Orive et al., 2016), ANOVA reveals that transcrip-
tomic variance is dominated by genetic differences, or at
any rate differences between donors’ specimens, which
holds not only for the whole transcriptome but also for
the majority of genes taken individually (Figure S1). The
proportion of variance explained by differences between
individuals increased with expression levels (Figures S1B
and S1D), suggesting that genes not showing high suscep-
tibility to genetic differences due to their low expression in
iPSC are likely to do so in other tissues.
Spurious Differential Expression Is Exacerbated by
Including Multiple iPSC Clones per Individual
Given the very large number of genes showing individual-
dependent differential expression, the comparison of unre-lated individuals—as in the traditional and currently most
prevalent design of iPSC-based modeling studies—will
inevitably lead to the identification of differentially ex-
pressed genes (DEGs) that are only spuriously associated
to the comparison of interest. This risk is further com-
pounded by the fact that, very often, in-house controls or
standard ESC lines are compared with samples received
from collaborating centers, introducing a further con-
founding factor for the conditions under study.
To assess the risk of such spurious results depending on
different experimental designs, we performed a series of per-
mutation analyses on both iPSC datasets. We performed
more than15,000differential expressionanalyses (DEAs)be-
tween random sex-balanced groups of varying sizes and de-
signs (illustrated in Figure 1A). In particular, we tested three
types of experimental design: (1) comparisons between un-
related individuals using a single clone per individual, (2)
comparison between unrelated individuals using two clones
per individual, and (3) comparison between a group of indi-
viduals and different clones from the same individuals.
Random comparisons showed a surprisingly high fre-
quency of ‘‘spurious’’ differentially expressed genes (Fig-
ures 1B and 1D). In contrast, basic measurements onStem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017 1785
cell morphology, which are available for a small subset of
the HipSci samples (28 clones from 14 individuals), did
not show such a dominant dependence on genetic differ-
ences (Figure S2B), although this can reflect the technical
or intrinsic variability of the measurements (Figure S2A).
The fact that the comparisons between isogenic clones
(Figures 1C and 1E) show very little spurious DEGs even
at small sample sizes indicates that the much higher
spurious results in the other two comparisons are related
to genetic differences. In addition, it warrants the use of
controls established by genetic correction of the patient-
derived cells when this is cost-effectively commensurate
to the specific objective.
Most notably, using more than one iPSC clone per
individual results in amajor increase in spurious DEGs (Fig-
ures 1B and 1D). Furthermore, and in contrast to
comparisons involving single clones which show a clear
downward trend upon increasing sample size, such a trend
appears absent from the comparisons with two clones per
individual. As expected given themuch higher genetic het-
erogeneity of the NHLBI dataset (Figure S3), the distribu-
tion of ‘‘spurious’’ DEGs was considerably higher (Fig-
ure 1D). Nevertheless, we could observe the same pattern
as in the HipSci dataset, albeit stronger, when using one
versus two clones per individual. Importantly, whenmanu-
ally adding ‘‘true’’ differential expression (see below), using
two clones per individual resulted in a dramatic increase of
the false discovery rate (FDR) (Figure S4). Together, these re-
sults call into question the widespread habit (also en-
trenched thus far in the guidelines of this journal) of
including more than one iPSC clone per patient.
This finding, however, should not come as a surprise, for
the statistical methods commonly used in gene expression
analysis assume that replicates are independent. For
instance, the edgeR manual recommends summing the
read counts of technical replicates before DEA instead of
treating them as bona fide replicates. The reason is simple:
treating technical replicates as independent artificially re-
duces the variability of the group’s mean. The same applies
to treating iPSC clones from the same individual as inde-
pendent when they are clearly not (at least in terms of
the overriding contribution of genetic makeup to the vari-
ance under study). While multiple clones per individual
improve the internal robustness of the results, their inclu-
sion hampers their generalizability to other individuals,
unless appropriate methods are employed (see below).
Genes Recurrently Found Differentially Expressed
across Random Individuals Are Related to
Fundamental Developmental Processes
Importantly, the spurious DEGs are not limited to modest
fold changes, andnearly half (48%) of themchange by a fac-
tor of more than 2 (Figure 2A), indicating that a simple fold-1786 Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017change threshold cannot adequately address the problem.
Some genes are found differentially expressed in the permu-
tation DEAsmuchmore often than others—in fact 98 genes
are differentially expressed inmore than20%of the compar-
isons (Figure 2B)—which prompted us to investigate the
nature of these recurrentDEGs in theHipSci dataset. Surpris-
ingly, the top 100 DEGs show very strong enrichment for
genes associated with both early developmental processes
(nearly 9-fold enrichment for gastrulation-related genes)
and aging (6-fold) (Figure 2C). In addition, and as previously
reported (Adamo et al., 2015), genes related to the extracel-
lularmatrix (ECM)organizationwere also strongly enriched.
The same enrichment for ECM-related genes appears in the
larger set of all recurrent DEGs (Figure 2D), as well early
developmental processes. Since the background used for
the enrichment analysis excludes genes that are not ex-
pressed in iPSC, we can exclude that these enrichments
are merely due to the pluripotent state, and instead must
conclude that they reveal instead an unexpected degree of
genetic variability in the expression of these genes, possibly
linked to an evolutionarily selected increased robustness of
the system to their variation. This result is in line with the
enrichment, among iPSC-specific expression quantitative
trait loci, for targets of pluripotency factors (Kilpinen et al.,
2016).
Despite the significance of these enrichments, it would
be still theoretically possible that these genes are largely
irrelevant to the fully formed organism. To assess this pos-
sibility, we tested whether the recurrent DEGs as well as the
top 100 recurrent ones were enriched for genes found to be
homozygously knocked out in healthy individuals (Sulem
et al., 2015), but could find no significant relationship
(Figure S5A). Nor was there any significant relationship
between the frequency of a gene being differentially ex-
pressed across permutations and the prevalence of CNVs
affecting that gene in the general population based on
Exome Aggregation Consortium (ExAC; Kosmicki et al.,
2017) data (Figures S5B and S5C).
Thus, the fact that somegenesare recurrently founddiffer-
entially expressed between random individuals does not
necessarilymean that they aremedically irrelevant. Indeed,
pathogenicmechanismsmightwell be related to similar but
subclinical phenotypic variations inhealthy individuals. An
interesting example is the recent finding that variation in
theGTF2I gene, a transcription factor hemizygously deleted
inWilliams-Beuren syndrome and associated with its socio-
cognitive phenotype, is associated with anxiety in the gen-
eral population (Jabbi et al., 2015). Therefore, we estimated
the likelihoodof recurrentgenesbeingdisease-significantby
looking at their overlap with known disease genes from the
database of OnlineMendelian Inheritance inMan (OMIM).
While OMIM genes were more likely to be differentially
expressed between random individuals (p  3 3 1016 by
Figure 2. Description of the Genes Recurrently Found Differentially Expressed across iPSC from Groups of Random Individuals
(A) Distribution of fold changes across spurious DEGs of all HipSci permutations.
(B) Distribution of the proportion at which each gene appears differentially expressed. Dashed lines delineate the quartiles while the blue
line indicates the threshold for ‘‘recurrent genes.’’ The green line represents the distribution of particularly recurrent genes found by
expectation maximization-based mixture modeling.
(C) Most specific enriched gene ontology terms among the top 100 most recurrent genes. FDR, false discovery rate.
(D) Top most specific enriched gene ontology terms among the recurrent genes (>6% chance being found differentially expressed).
In (C) and (D) FDR is shown in red and fold enrichment in blue. See also Figure S5.Mann-Whitney test), the enrichment was very small (Fig-
ure S5A). Together, these results suggest that genes recur-
rently found differentially expressed across individuals are
neither depleted nor considerably enriched for genes more
likely to be medically relevant.
Sensitivity across Experimental Designs and Sample
Sizes
We next assayed to what extent different experimental de-
signsandsample sizes coulddetect inputdifferential expres-
sion. To this endwe repeated thepermutationanalysis, each
time introducing a total of 100 DEGs at five different foldchanges, and distributed across different expression levels
(see Experimental Procedures). Notably, the two datasets
showed large differences in overall sensitivity (Figures 3
and S6), possibly owing in part to differences in coverage
and different degrees of technical standardization.
When comparing single clones from unrelated individ-
uals, the sensitivity seemed to largely plateau after six indi-
viduals per group (Figure 3A). Using two clones per individ-
ual resulted in an increase in sensitivity, albeit at the cost of
a massive loss in specificity, as shown above (Figures 1 and
S4). Isogenic controls also showed a marked improvement
in sensitivity in one of the datasets (Figure 3C).Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017 1787
Figure 3. Sensitivity of Different Experimental Designs across Fold Change and Expression of the DEGs in the HipSci Dataset
(A–C) Using a single clone per individual (A), using two clones per individual (B), and comparing isogenic clones (C). Each square rep-
resents the average across 300 permutations.
(D) Sensitivity when comparing a small cohort with a large set of unrelated controls.
(E) Distribution of false positives when comparing a small cohort with a large set of unrelated controls.
See also Figure S6.In all cases, the sensitivity was quite good for high fold
changes, but rapidly decreased with fold change and read
count. Fold changes of 1.5, which are especially relevant
in the context of gene duplications, were particularly
difficult to detect, and most of them are unlikely to be1788 Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017detected unless the genes are very stable or highly ex-
pressed. This is particularly relevant given the importance
of copy-number alterations for a variety of diseases
(McCarroll and Altshuler, 2007; Cook and Scherer, 2008;
Luo et al., 2012).
(legend on next page)
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Finally, since it is relatively common for laboratories
specialized in cell reprogramming to have assembled banks
of control iPSC lines against which disease-specific lines
can be compared, we also evaluated the sensitivity of de-
signs comparing only three patient-specific lines with a
larger set of controls (n = 10). While such design provided
fair sensitivity (Figure 3D), it could not achieve the same
degree of spurious DEG minimization as more balanced
groups (Figure 3E).
A good experimental design should optimize both sensi-
tivity and specificity. While the ideal tradeoff between the
two ultimately depends on the context, specificity (type I
error) is most often considered at least as important, if
not more so, than sensitivity (type II error). Therefore,
while using multiple clones per individual increased sensi-
tivity (albeit not necessarily more so than using more indi-
viduals), it did so at a much larger cost in specificity. This
favors increasing the number of individuals instead of the
number of clones per individual. Whenever this is not
possible, or when the data have already been generated,
analysis methods ought to be used that take into account
the samples’ interdependence.
Comparison of Methods for Dealing with Multiple
Clones
Although multiple iPSC clones per individual cannot be
considered full replicates, they nevertheless provide useful
informationon someaspects of the variability.We therefore
tested whether more appropriate statistical methods, in
particular approaches based on mixed models and
treating the individual as a random-effect variable, could
harness the availability of additional clones while keeping
good control of false positives. Since such modeling
methods are not typically implemented in RNA-seq anal-
ysis packages, we tested alternative methods of applying
or approximating them in this context (see Experi-
mental Procedures), and compared their ability to distin-
guish ‘‘true’’ inputted DEGs from ‘‘spurious’’ ones (Fig-
ures 4A and 4B). The first implementation relies on the
duplicateCorrelation function of the limma R package (Law
et al., 2014), which approximates mixedmodels, in combi-Figure 4. Comparison of Analysis Methods
(A and B) Sensitivity and specificity of analysis methods when deali
Shown are the averages of 30 permutations for each method. The glmm
this FDR threshold.
(C) Sensitivity when using the dupCor approach and an FDR < 0.01 th
(D–G) Comparison of edgeR’s classic (exact test) and paired analysis (G
paired analysis leads to a major increase in ‘‘spurious’’ DEGs (D) for a ve
in the FDR (F) but little impact on the ROC curve (G).
(H) Adjusting the FDR of differentially expressed genes on the basi
improvement in the FDR (based on 300 permutations of compariso
individual, HipSci dataset).
1790 Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017nation with a voom-based analysis (Ritchie et al., 2015).
This was compared with a standard voom-based analysis
of one or two clones per individual, as well as to a voom-
based analysis previously summing the clones of each indi-
vidual (sumReps), as recommended for technical replicates.
Finally, we also tried alternative implementations of mixed
models, in particular: (1) a glmm-based application of
mixed models using the quasi-Poisson distribution (the
negative binomial not being implemented in the glmmML
package) on normalized counts; (2) a lme4-based applica-
tion of mixed models on voom-transformed normalized
counts; and (3) a lme4-based application of mixed models
on DESeq2’s variance-stabilizing transformation (Love
et al., 2014). As expected, using one clone per patient re-
sulted in the smallest spurious/FDR at a nominal FDR <
0.05, which was instead very high when using two clones
per patient without special treatment. This effect could be
mitigated to different extents, and with different impacts
on sensitivity, by the different approaches. In particular,
limma’s duplicateCorrelation appeared to offer the best per-
formance at nominal FDR < 0.05 (Figure 4B) and the best
receiver-operating characteristic (ROC) curve at high speci-
ficity (Figure 4A), followed by the sum of replicates. While
none of these approaches yielded a specificity equivalent
to the use of single clones per individual at nominal
FDR < 0.05, the last two came very close, enabling a consid-
erable gain in sensitivity and having a superior net area un-
der the ROC curve, indicating that they are advisable, espe-
cially with a slightly more stringent threshold. Indeed,
using limma’s duplicateCorrelation approach with an FDR
threshold of 0.01 retained much of the increase in sensi-
tivity of using two cloneswith a specificity superior to using
a single clone (Figures 4Band4C).We therefore recommend
this approach, i.e., limma’s duplicateCorrelation with a
slightly more stringent significance threshold, for analyses
of datasets involving more than one clone per individual.
Paired Analysis in the Context of Isogenic Controls
Results in Increased False Discoveries
Popular differential expression methods, such as edgeR
(Robinson et al., 2010), DESeq2 (Anders and Huber, 2010;ng with multiple clones per patient (three individuals per group).
-based method is not shown in (B) because it led to no positive at
reshold.
LM-based) for paired experimental designs. At a q < 0.05 threshold,
ry modest increase in sensitivity (E), resulting in a massive increase
s of their frequency in the permutations results in a considerable
ns between two groups of four individuals, using two clones per
Figure 5. Survey of the 2016 iPSC Dis-
ease-Modeling Studies
(A) Total number of individuals (all condi-
tions pooled) from which the studied iPSC
lines were derived.
(B) Total number of iPSC clones studied (all
conditions pooled). The dashed lines in (A)
and (B) indicate the median and the solid
lines indicate the mean.
(C) Distribution of the probability of genes
to be found differentially expressed in
random permutations, comparing all genes
(left) with the DEGs of two sample iPSC-
based studies from our survey (right). The
red line indicates the mean and the blue
line indicates the median. The p values
were calculated from a Mann-Whitney test
comparing the distributions.Love et al., 2014), and limma/voom (Law et al., 2014;
Ritchie et al., 2015), implement generalized linear models
to provide the possibility to analyze more complex experi-
mental designs than a binary comparison between two
groups. In the context of studies involving isogenic or
half-matched controls (i.e., unaffected sibling or parent),
this permits comparison of each patient-derived line with
its matched control and the gauging of consistent relative
changes (i.e., background + condition). Such a paired
analysis naturally increases sensitivity, but at the cost of
increasing the degrees of freedom of the tested model.
We therefore compared the sensitivity and occurrence of
spurious DEGs in paired versus classical analysis (Figures
4D–4G). Of note, while paired analysis did indeed result
in an increase in sensitivity (Figure 4E), it also massively
increased the detection of spurious DEGs (Figure 4D), lead-
ing to an important net increase in the FDR (Figure 4F).
This, however, had no noticeable impact on the ROC curve
(Figure 4G), indicating that the paired analysis can be used
provided that an accordinglymore stringent FDR threshold
is adopted.
Knowledge of Variable Genes Can Improve the False
Discovery Rate
Since genes are variously likely to be found differentially
expressed across random groups of individuals, we assessed
whether the knowledge of this probability for each gene
could help adjust the FDR of differential expression anal-
ysis. Using a very simple approach based on the frequency
of the gene and fold change among spurious differential
expression across permutations (see Experimental Proced-
ures), we adjusted the nominal FDR of the differential
expression analysis on the basis of the results of our permu-
tation analysis, which resulted in a considerable improve-ment of the effective FDR (Figure 4H). This approach thus
offers a proof of concept of the utility of such large datasets
in the interpretation of iPSC-based studies, paving the way
to more complex approaches, for instance involving hy-
pothesis weighting or Bayesian updating, which can prob-
ably make even greater use of this information on variable
genes. This being said, such corrections should be inter-
preted with care given that, as emphasized earlier, it could
well be that genes whose expression is highly variable in
the general population are nevertheless associated with
the conditions under study or related subclinical traits.
A Considerable Proportion of Published iPSC-Based
Disease-Modeling Studies Has Insufficient Precision
To assess the impact of our observations for the iPSC
modeling field, we sampled the most recent iPSC disease-
modeling literature, selecting 77 studies published in
2016 (see Experimental Procedures and Table S1). The
vast majority (79%) of the studies relied on unrelated con-
trols, with 10% using a combination of unrelated and
half-matched controls and 10% using isogenic controls.
The distribution of the total number of individuals (all con-
ditions pooled) fromwhich the iPSC lines were derived and
the total number of iPSC clones used are plotted in Figures
5A and 5B. Importantly, 41% of the studies usedmore than
one clone per individual (the proportion increases to 51%
in studies involving at least six individuals in total) without
adopting appropriate statisticalmethods, which as we have
shown can artificially inflate significance and lead to many
false positives.
As an example, we took two studies focusing on the tran-
scriptome as relevant endophenotype and that reported
lists of DEGs (several studies involving transcriptomics
did not report such a list, and some did not even makeStem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017 1791
the data available). The first (PubMed ID 27846841)
involved a rather large number of individuals per group
(eight versus seven), while the second (PubMed ID
27662211) included a fairly small number of individuals
(three per group). Despite the difference in cell type, the
genes reported as differentially expressed by these studies
had a significantly higher probability of being differentially
expressed in our random permutations (Figure 5C), partic-
ularly for the study involving a small sample size, which
questions the specificity of at least a subset of these genes
for the disease under study.
This being said, it must be emphasized that many of the
studies reviewed were not exclusively based on (and in
some cases not even involving) transcriptional pheno-
types. In light of some of the results described here (Fig-
ure S2) as well as evolutionary considerations, it is possible
that lower-content assays measuring, for instance, cellular
phenotypes could show a lower rate of spurious results
due to genetic differences. Moreover, the combination of
independent lines of evidence can often strengthen results
obtained from weak (from an intrinsic statistical point
of view) studies. Nevertheless, the present results indi-
cate that a considerable proportion of iPSC-based disease-
modeling studies, especially when based on next-genera-
tion sequencing experiments, may present a high rate of
false positives and (unless one focuses on very highly ex-
pressed genes and/or fairly large fold changes, i.e., >2) be
underpowered.An R Package to Estimate the Power of iPSC Study
Designs
Lastly, we provide the R package iPSCpoweR, available on gi-
thub, to reproduce all of the analyses performed in the pre-
sent study (including multi-threaded DEA permutations,
plots, etc.) and conduct further power analysis. We hope
that this resource can help scientists in the field to make
more informed decisions regarding the design of future
iPSC-based studies.DISCUSSION
The predominance of inter-individual differences in
explaining transcriptional variability has already been
reported (Rouhani et al., 2014; Burrows et al., 2016;
Carcamo-Orive et al., 2016). These datasets are likely to un-
derestimate human genetic variability due to the popula-
tions sampled (Figure S3); in particular, all individuals
from which the HipSci lines used were derived are
described by the consortium as ‘‘white,’’ and most of
them are labeled as being of English origin. The predomi-
nance of inter-individual differences is in line with the
surprising degree of genetic variation in human gene1792 Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017expression regulation (Kasowski et al., 2013; Mele´ et al.,
2015; Barrera et al., 2016). Indeed, Barrera et al. (2016)
showed that the median human genome harbors 60 het-
erozygous and 20 homozygous missense SNPs that change
the amino acid sequence of transcription factor (TF) DNA
binding domains, resulting in changes in affinity and/or
specificity in at least 75% of the cases. Together with varia-
tions in TF target sites and other changes affecting DNA
conformation, these can lead to wide differences in gene
expression.
While the present results were obtained from the tran-
scriptome of pluripotent cells, the impact is unlikely to
be smaller in differentiated cell types. Indeed, Banovich
et al. (2016) recently reported that regulatory variation
between individuals is lower in iPSCs than in two differen-
tiated cell types. Furthermore, given the difficulty in ob-
taining samples from patients harboring rare mutations,
it is not uncommon for probands’ and control lines to
have different origins, and hence potentially confounding
background genomic differences. It is therefore likely that
the ‘‘spurious’’ differences observed here in the permuta-
tion DEAs are relatively conservative estimates. On the
other hand, while the present study aimed at measuring
the impact of spurious differential expression, it is possible
that spurious differences passing multiple testing correc-
tion in this context, namely with little real differences be-
tween groups, might not necessarily pass it if the two
groups show overriding transcriptional differences related
to the condition of interest. This is due to the fact that
popular correction methods (e.g., Benjamini-Hochberg)
are rank based; hence the larger the transcriptional effect
of the studied condition, the smaller the number of
spurious DEGs will be. Finally, for specific cellular or func-
tional assays with a proven more direct relationship to the
ultimate traits under fitness selection, it is plausible that
compared with transcription they are more robust and
less influenced by genetic variation.
Akeyobservationof thepresent study is that, contrary toa
widespread practice, using multiple clones per individual
canbeverydetrimental to the robustness of the studyunless
appropriate statistical methods are adopted. This represents
a critical warning for the iPSC modeling field, since most
leading studies, including our own work (Adamo et al.,
2015), in a large number of publications have embraced
the thus far current standard of including multiple clones
per individual without accounting for their interdepen-
dence in the statistical analysis. One way of doing so,
harnessing the additional power of multiple clones while
keeping a good control of false positives, was through the
combination of the voom and duplicateCorrelation functions
implemented in the limmapackage (Lawet al., 2014;Ritchie
et al., 2015) used with a slightlymore stringent significance
threshold (here FDR < 0.01). This approach dramatically
Figure 6. Summary of the Precision and Sensitivity of the Main
Experimental and Computational Designs
The numbers in the data points represent the number of individuals
per group. Triangles indicate isogenic lines, squares indicate
unrelated individuals with one clone per individual, and circles
indicate unrelated individuals with two clones per individual, with
standard (green) or mixed-models (pink) analysis (through limma’s
duplicateCorrelation). With a standard analysis, using two clones
per individual has a catastrophic impact on the FDR. Using mixed
models, however, dramatically improves the FDR, making the
design equivalent (albeit with a much larger total number of clones
profiled) to an isogenic experimental design.reduces the rate of false or spurious discovery, making the
design equivalent to an isogenic experimental design, albeit
with a much larger total number of clones profiled.
On the basis of our results (summarized in Figure 6), we
propose the following recommendations. Isogenic controls
corrected for the mutation, which we modeled here using
different clones from the same individual, represent an
ideal albeit cost- and time-intensive experimental design.
Using two clones per individual with the aforemen-
tioned mixed-models approach offered a comparable per-
formance. In both these cases, using at least three individ-
uals per group (ideally four or more) offered a decent
control of false positives, with additional individuals offer-
ing increases in sensitivity. When single clones from
unrelated individuals are used, a strict minimum of four
individuals per group should be used. In general (and to
the extent that such comparisons were made possible by
the current datasets), more than six to seven individuals
per group offered only marginal improvements. Finally,
the use of multiple clones per individual without adequate
statistical treatment of their interdependence is stronglydiscouraged. Just like technical replicates, different clones
from the same individuals capture only a portion of the
biological variability, and treating them as statistically in-
dependent artificially reduces the variability of the group’s
mean.
Part of the problem therefore lies in deep ambiguities
regarding themeaning of technical andbiological replicates.
Indeed, whether a replicate is biological or technical has
become an increasingly vague notion that thrives in the di-
versityofpossible answers, andpartly for good reasons: there
are not two but diverse possible degrees of replication, each
capturing different layers of variability. Moreover, as biolog-
ical processes have gradually been mastered in the labora-
tory, they have increasingly ceased to be in themselves ob-
jects of investigation and have joined the scientist’s toolkit,
so that in many contexts biological processes have become
purely technical operations. In the language of the historian
of scienceHans-Jo¨rgRheinberger, theywent from ‘‘epistemic
things’’ to ‘‘technical objects’’ (Rheinberger, 1997). It might
therefore be useful to replace the distinction between tech-
nical and biological replicates for one inspired by these
categories. In this view, technical replicates are replicates
capturing the variability of (all or some of) the processes
through which we study a phenomenon, whereas epistemic
replicates capture, in addition to this technical variability,
the variability in the phenomenon itself under study. The
concepts are therefore relative to the questions being asked.
Insofar as the aimof a study is to uncover disease-relevant ef-
fects of, say, a pathogenic mutation or copy-number alter-
ation, epistemic replicates should capture the variability of
the patients harboring the disease, and hence iPSC clones
represent technical replicates. If, instead, the aim is to learn
about theeffects agivengenetic lesionagainst a specificback-
ground genome, or about the impact of reprogramming-
induced changes on the expressivity of that lesion, iPSC
clones represent epistemic replicates.
More clarity in choosing and reporting the type and
degree of replication would greatly help to improve the
robustness of findings in iPSC-based studies.EXPERIMENTAL PROCEDURES
Samples Used
The description of the HipSci samples used can be obtained using
the getSamplesInfo function of the package. A summary of the
samples is shown in Figure S3, and the SRA-run IDs are listed in
Table S2. All the samples not cultivated on feeders, not associated
to a disease, and available on open access at the time of this study
were used (a total of 62 lines from 47 individuals, including 15 in-
dividuals with two clones).
From the NHLBI NextGen consortium dataset, we included only
lines that have been reprogrammed from the same type of cells
(Erythroblasts) using the same rna method (Life-Tech GITC) andStem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017 1793
cultured in the sameMatrigel preparation (a total of 107 lines from
37 individuals were used). These are listed in Table S2, and are
available (both counts and annotation) in the R package
(data(‘‘GSE79636’’)).
RNA-Seq Quantification
For the HipSci data, RNA-seq quantification was performed using
Salmon v6.1 (Patro et al., 2016), using FMD indexes and the
Refseq transcript annotation. The expression matrix is available
through the getTxExpr and getGeneExpr functions of the package.
For all analyses, the TMM normalization was used (Robinson
and Oshlack, 2010). For the NHLBI NextGen data, we used the
quantification made available by the authors on the GEO (GEO:
GSE79636).
ANOVA
The analysis of transcriptional variance (Figure S1) was performed
on log-transformed transcripts per million (TPM) values aggre-
gated at the gene level. Both linear models (Figures S1A and
S1B) and mixed random-effect models implemented by the lme4
R package (Figures S1C–S1E) were used. The analysis can be repro-
duced using the transcriptionalVarianceExplained function of the
package.
For the ANOVA in cell morphology, we used only the
data collected on the middle concentration of fibronectin.
The data can be accessed from the cellpheno data object of
the package, and the ANOVA can be reproduced using the
cellphenoVarianceExplained function.
Differential Expression Analysis
With the exception of the mixed-models approaches (Figures 4A,
4B, and 6), all differential expression analysis was performed
with edgeR v.3.12.1, which has among the most robust perfor-
mances (Germain et al., 2016). For testing, only genes for which
at least two samples had more than ten reads were considered.
For the paired analysis, generalized linear models and the likeli-
hood-ratio test was used; otherwise the exact test was used. See
the edgeRwrapper function for the exact code.
In the comparison of approaches to dealing with multiple
clones per individual (Figures 4A and 4B, pink data points
in Figure 6), we used limma v.3.28.5. The dupCor method, as
implemented in the voomWrapper function of the iPSCpoweR
package, uses a two-step voom transformation (before calling
duplicateCorrelation, and after, including the output of the
function). The SumReps method simply sums, for each indi-
vidual, the read counts of all clones, and is implemented in
the voomWrapperSumReps function. The lmer- and glmm-based
methods are respectively implemented in the voomLmerWrapper,
vstLmerWrapper, and glmmWrapper functions, and use the individ-
ual as a random-effect variable (i.e., 1 + [1jindividual] + group).
The lmer-based methods rely on the drop1 approach with a chi-
squared test for statistical significance.
Input/‘‘True’’ Differential Expression
To assess sensitivity, we introduced differences between the groups
by enabling the addDE option of the package’s permutation func-
tions, with default settings. The differences are introduced multi-1794 Stem Cell Reports j Vol. 8 j 1784–1796 j June 6, 2017plying a gene’s read count, in each sample of one of the groups,
by a predefined fold change. For each fold change (1.25, 1.5, 2,
3, 5, and their inverse), ten geneswere randomly selected spanning
the range of expression levels of the tested transcriptome, for a
total of 100 introduced DEGs in each analysis. Importantly, this
is making the assumption that, all other things being equal,
‘‘real’’ differentially expressed genes have an intra-group variability
comparable with other genes.
Permutation Analysis
Permutation DEA analyses were performed using the
DEA.permutateIndividuals and DEA.permutateClones functions of
the package, using the default setting except for the addition of
the expression filter (at least two samples having more than ten
reads). Permutations thatwere not balanced for sexwere discarded.
For the NHLBI dataset, we instead ensured that the comparisons
were balanced for technical batches. For comparisons involving
12 or fewer total individuals, only the individuals with more
than one available iPSC clone were used in order to maximize
the comparability with other experimental designs. For compari-
sons involving more than 12 individuals in total it was, however,
necessary to use the whole cohort of samples to have a sufficient
number of valid comparisons.
The permutation analysis of cellular morphology (Figure S2) can
be reproduced with the cellpheno.permutateIndividuals function.
Data-Informed Correction of the Q Values
For Figure 4H, the nominal FDR values reported by edgeRwere cor-
rected using the multiProbSpurious function of the package. The
function reports, for each tested gene, the frequency of the gene’s
absolute fold change or higher in the distribution of fold changes
of the spurious DEG, as well as the frequency at which the given
gene was found differentially expressed, in the union of all permu-
tations of the HipSci dataset. For genes whose fold change was
plausible in the distribution of spurious fold changes (p > 0.05),
we then replaced edgeR’s FDR by the frequency of the given gene
in the permutations, if greater.
Gene Ontology Enrichment Analysis
Gene Ontology enrichment analyses were performed using the
goseq R package (Young et al., 2010) against the background of
tested genes (passing the filter of >10 reads in >2 samples), correct-
ing for eventual RNA-seq transcript length bias, and excluding
genes without annotation. Categories with at least ten genes and
maximum 1,000 genes were considered. To increase the informa-
tiveness of the terms, we removed terms with significantly en-
riched children terms.
Selection of iPSC-Based Disease-Modeling Studies
For the brief review of experimental designs used in recent iPSC
disease-modeling studies, a PubMed search for ‘‘Induced pluripo-
tent stem cells’’ OR ‘‘iPSC’’ was performed and publications pub-
lished in 2016 were considered. Only studies performing human
iPSC-based modeling of specific diseases were considered (reviews,
studies involving therapeutic application of iPSC derivatives; using
direct conversion or reporting the development/improvement of
technologies were discarded), and reports of the mere generation
of single lines were discarded. For a large number of studies, the
number of individuals/lines had to be inferred from the figures
(lines were considered if at least some of the assays were performed
on them beyond the validation of their pluripotency). Of the 81
publications meeting these criteria (see Table S1), three were
excluded as not indicating the number of lines involved and four
more were considered ambiguous in this respect, so that 74 studies
were finally used to compile the number of clones/individuals (see
Table S1).
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Figure S1: Differences between 
individuals dominate transcriptional 
variability for most of the genes. A-B: 
Analysis of variance in the HipSci dataset 
based on linear regression. C-D: Analysis 
of variance in the HipSci dataset based on 
mixed modeling (individual considered as 
random effect). B and D shows the density 
maps of of the proportion of each gene's 
variability explained by differences in 
individuals, according to the gene's 
expression level (in log Transcripts Per 
Million). E: Analysis of variance in the 
GSE79636 dataset based on mixed 
modeling.
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Figure S1 (related to Figure 1)
  
Figure S2: variability of iPSC cellular morphology. A: Proportion of the variability in 
each cellular feature (rows) explained by each variable (column) based on linear 
regression. In all cases, the largest component of variability is attributable to technical 
variation. B: Distribution of p-values when testing for differences in each cellular 
feature across random groups of 3 individuals (2 clones per individual). A t-test on log-
transformed values was used.
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Figure S2 (related to Figure 1)
  
Figure S3: Overview of the samples used. A: Overview of the samples used in the HipSci dataset. 
B: Overview of the samples used from the NHLBI dataset.
A: samples from the HipSci cohort
B: samples from the NHLBI NextGen consortium (GSE79636)
Figure S3 (related to Figure 1)
  
Figure S4: Effect of using multiple clones per individual on the proportion of spurious/false DEGs among all 
DEGs at nominal FDR<0.05. A: In the HipSci dataset. B: In the NHLBI (GSE79636) dataset.
Figure S4 (related to Figure 1)
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Figure S5: Spurious differentially-expressed genes from the permutation analyses are 
neither depleted nor considerably enriched for medically-relevant or genetically variable 
genes. A: Distribution of the frequency at which genes of different subsets were found 
differentially-expressed across random individuals. 'OMIM' and 'notOMIM' stand for the sets of 
genes that respectively are or are not in the Online Mendelian Inheritance in Man (OMIM) 
database, while 'KO' and 'notKO' stand for the sets of genes that respectively are or are not among 
the genes found homozygously knocked-out in healthy individuals (Sulem et al. 2015). B: Density 
map showing, for each gene, the frequency of its differential expression across permutation DEAs 
(x axis) and the frequency with which it is affected by CNVs in ExAc. C: Density map showing, for 
each gene, the frequency of its differential expression across permutation DEAs (x axis) and the 
CNV score in ExAc.
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Figure S6: Sensitivity of different experimental designs across foldchange and 
expression of the DEGs in the GSE79636 dataset.  A: using a single clone per individual. B: 
using two clones per individual. C: comparing isogenic clones. Each square represents the 
average across 50 permutations.
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Figure S6 (related to Figure 3)
